CVR 38732730Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)FrederiksbergFounded 22 Jun 2017
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about AdaptVac ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
9
CVR registry, Aug 2026
-1 (-10%) over 12 months
Gross profit
-3.2M
DKK, annual report 2025
-11.6M on 2024
Result
-7.1M
DKK, annual report 2025
Equity
10.8M
DKK, annual report 2025
NextGen Vaccines Holding ApSCVR 38706721, 50% to under 66.7% of capital and votes, since 21 Jun 2017
EXPRES2ION BIOTECHNOLOGIES ApSCVR 32770487, 33.3% to under 50% of capital and votes, since 21 Jun 2017
Willem Adriaan De Jonghsince 22 Jun 2017
Adam Frederik Sander Bertelsensince 22 Jun 2017
CVR 3277048733.3% to under 50% of capital and votesnotified 1 Feb 2021since 21 Jun 2017
CVR 3870672150% to under 66.7% of capital and votessince 21 Jun 2017
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
22 Jun 2017 to 8 Nov 2026.
2 Oct 2017 to 8 Nov 2026.
Aug 2026, monthly: 9 employees, 6 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 6 | 5 | 5 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 8 | 7 | 6 | 7 | 7 | 6 | 7 | 8 | 8 | 7 | 8 | 7 | 8 | 8 | 7 | 7 | 7 | 8 | 7 | 8 | 8 | 8 | 8 | 7 | 7 | 9 | 8 | 10 | 10 | 9 | 10 | 10 | 9 | 10 | 10 | 10 | 8 | 9 | 8 | 10 | 8 | 8 | 9 |
| FTE | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | 5 | 4 | 6 | 5 | 5 | 6 | 7 | 6 | 6 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 5 | 7 | 5 | 6 | 6 | 6 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | 6 | 5 | 6 | 6 | 6 | 7 | 8 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Mar 2019 to Aug 2026.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 1,331 | -1,582 | 69,205 | 8,393 | -3,161 |
| Operating profit | -2,022 | -5,802 | +64,035 | +2,944 | -9,147 |
| Result for the year | -1,782 | -4,795 | +50,886 | +1,714 | -7,054 |
| Equity | 12,557 | 7,762 | 58,648 | 17,862 | 10,809 |
| Total assets | 15,194 | 14,015 | 98,167 | 20,036 | 22,976 |
| Employees (average) | 5 | 6 | 6 | 6 | 7 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -93.6% | -219.6% | n.m.note 1 | -87.9% | -137.7% |
| EBITDA | Not reportednote 2 | -5,799 | 64,058 | 2,967 | -9,127 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | Not reportednote 2 | n.m.note 3 | 92.6% | 35.4% | n.m.note 3 |
| Employee growth (vækst i antal ansatte) | 66.7% | 20% | 0% | 0% | 16.7% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -11,942note 4 | -9,104note 4 | -2,778note 4 | -14,953note 4 | -9,494 |
| Gearing, NIBD / EBITDA | Not reportednote 2 | n.m.note 5 | Net cashnote 4 | Net cashnote 4 | n.m.note 5 |
| ROIC (afkast af investeret kapital) | n.m.note 6 | n.m.note 6 | 186.6%note 4 | 8%note 4 | -337.8%note 7 |
| Capex (investeringer i anlægsaktiver) | Not reportednote 8 | 69note 9 | 0note 10 | 0note 10 | 0note 10 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -12,468note 4 | -10,741note 4 | 10,367note 4 | -14,499note 4 | -11,310 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 12 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 30 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 14 May 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 17 May 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 26 Jun 2022
Each registered value from the day it took effect, newest first.
From CVR, read 8 Nov 2026. Text such as the signing rule and purpose is shown as registered.
12 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Bestyrelse:
Fratrådte:
Allan Rosetzsky, den 10.06.2026.
Tiltrådte:
Martin Roland Jensen, den 10.06.2026.
Vedtægter ændret: 30.09.2025
Ny adresse: Nordre Fasanvej 215, 2000 Frederiksberg
Ny kommune: Frederiksberg
Vedtægter ændret: 05.05.2022
Revision:
Tiltrådte:
CVR-NR. 14119299 PKF MUNKEBO VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, Hovedvejen 56, 2600 Glostrup, den 05.05.2022.
Ny adresse: Ole Maaløes Vej 3, 2200 København N
Ny kommune: København
Vedtægter ændret: 22.09.2021
Bestyrelse:
Fratrådte:
Willem Adriaan De Jongh, den 26.02.2020.
Bestyrelse:
Fratrådte:
Steen Søren Klysner, (formand), den 06.01.2020, Morten Agertoug Nielsen, den 06.01.2020.
Tiltrådte:
Morten Agertoug Nielsen, (formand), den 06.01.2020, Allan Rosetzsky, den 06.01.2020.
Vedtægter ændret: 15.11.2017
Selskabet tegnes af den administrerende direktør og en direktør iforening eller af 4 medlemmer af bestyrelsen i forening..
Vedtægter ændret: 02.10.2017
Ny adresse: Agern Alle 1, 2970 Hørsholm
Ny kommune: Rudersdal
Bestyrelse:
Tiltrådte:
Willem Adriaan De Jongh, den 02.10.2017, Ali El-Salanti, den 02.10.2017, Bent Ulrich Frandsen, den 02.10.2017, Steen Søren Klysner (formand), den 02.10.2017, Morten Agertoug Nielsen, den 02.10.2017, Adam Frederik Sander Pedersen, den 02.10.2017.
Direktion:
Fratrådte:
Willem Adriaan De Jongh, den 02.10.2017.
Tiltrådte:
Willem Adriaan De Jongh (adm. dir), den 02.10.2017.
Selskabet tegnes af Adam Frederik Sander Pedersen og Bent Ulrich Frandsen i forening eller af den samlede bestyrelse i forening..
Stiftelsesdato: 22.06.2017.
Virkningsdato: 22.06.2017.
Seneste vedtægtsdato: 22.06.2017.
Kapital:
kr. 50.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 50.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 32770487 EXPRES2ION BIOTECHNOLOGIES ApS, Agern Alle 1, 2970 Hørsholm, den 22.06.2017, CVR-NR. 38706721 NextGen Vaccines Holding ApS, c/o Advokatfirmaet Levin, Algade 34, 1. th, 4000 Roskilde, den 22.06.2017.
Direktion:
Willem Adriaan De Jongh, den 22.06.2017, Adam Frederik Sander Pedersen, den 22.06.2017.
Virksomheden tegnes af direktionen i forening..
Første regnskabsår:
22.06.2017 - 31.12.2017.
Regnskabsår:
01.01 - 31.12.
Formål:
Virksomhedens formål er at udvikle produkter og teknologi indenfor området vacciner og immunterapi samt hermed efter ledelsens skøn beslægtet virksomhed og serviceydelser.
1 registered in CVR.
P-number 1022555258Nordre Fasanvej 215, 2000 Frederiksberg
No other current company drawn.
